Expansion Of Aspire Higher Clinical Trial Programme For SPP100 (Rasilez/Tekturna)
Speedel Holding Ltd. (SWX: SPPN) highlighted today that Novartis is to expand the clinical trial programme with SPP100 (…
Speedel Holding Ltd. (SWX: SPPN) highlighted today that Novartis is to expand the clinical trial programme with SPP100 (…
Die Speedel Holding AG (SWX: SPPN) hat heute darauf hingewiesen, dass Novartis das Programm an klinischen Studien mit SP…
Data from the AVOID study published in this week's New England Journal of Medicine demonstrate that the first-in-class d…
Speedel (SWX: SPPN) today welcomed promising results from the latest SPP100 (Tekturna/Rasilez[1]Â) surrogate marker clin…
Speedel Holding Ltd (SWX: SPPN) today welcomes the promising results of SPP100 (Tekturna/Rasilez[1]Â) in the AVOID[2] Ph…
Speedel (SWX: SPPN) today welcomed the promising results of SPP100 (Tekturna/Rasilez[1]Â) in a Phase II clinical trial w…
Speedel (SWX: SPPN) begrüßte heute die von Novartis bekannt gegebenen viel versprechenden Ergebnisse zu SPP100 (Tekturna…